• Japanese
  • Korean
  • Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research publishes in-depth strategic intelligence reports in a broad range of professional industries, including, pharmaceuticals, medical devices, alternative energy, power, clean technology, oil and gas and chemicals. Their reports draw on in-depth primary and secondary research, proprietary databases and high quality analysis from their in house and external expert teams. Insights and analysis at the company, country and industry level includes competitor and market data, valuations, clinical & market trends, product pipelines and forecasts.

Filter
Title Search
1 - 25 of 501 Products Sort by Display
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Product code
369233
Published
August 1, 2016
Content info
176 Pages
Price
USD 4995
Sample available
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Published by
GBI Research
Product code
369232
Published
August 1, 2016
Content info
202 Pages
Price
USD 4995
Sample available
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
Published by
GBI Research
Product code
369231
Published
August 1, 2016
Content info
68 Pages
Price
USD 6995
Sample available
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
Published by
GBI Research
Product code
367993
Published
August 1, 2016
Content info
100 Pages
Price
USD 4995
Sample available
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
Published by
GBI Research
Product code
367992
Published
August 1, 2016
Content info
66 Pages
Price
USD 6995
Sample available
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
Published by
GBI Research
Product code
367991
Published
August 1, 2016
Content info
150 Pages
Price
USD 4995
Sample available
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
Published by
GBI Research
Product code
366603
Published
July 4, 2016
Content info
131 Pages
Price
USD 4995
Sample available
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Published by
GBI Research
Product code
363981
Published
June 16, 2016
Content info
143 Pages
Price
USD 4995
Sample available
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies
Published by
GBI Research
Product code
363980
Published
June 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies
Published by
GBI Research
Product code
363067
Published
June 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
358649
Published
May 1, 2016
Content info
144 Pages
Price
USD 4995
Sample available
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Published by
GBI Research
Product code
358647
Published
May 1, 2016
Content info
144 Pages
Price
USD 4995
Sample available
Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market
Published by
GBI Research
Product code
358648
Published
April 21, 2016
Content info
147 Pages
Price
USD 4995
Sample available
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
Published by
GBI Research
Product code
357639
Published
April 5, 2016
Content info
179 Pages
Price
USD 4995
Sample available
Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics
Published by
GBI Research
Product code
357638
Published
April 1, 2016
Content info
183 Pages
Price
USD 4995
Sample available
Frontier Pharma: Schizophrenia and Associated Indications - Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms
Published by
GBI Research
Product code
357637
Published
April 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs
Published by
GBI Research
Product code
357018
Published
March 10, 2016
Content info
70 Pages
Price
USD 6995
Sample available
Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies
Published by
GBI Research
Product code
355739
Published
March 1, 2016
Content info
151 Pages
Price
USD 4995
Sample available
Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns
Published by
GBI Research
Product code
355738
Published
March 1, 2016
Content info
130 Pages
Price
USD 4995
Sample available
Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes
Published by
GBI Research
Product code
354830
Published
February 16, 2016
Content info
79 Pages
Price
USD 6995
Sample available
Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments
Published by
GBI Research
Product code
354829
Published
February 11, 2016
Content info
136 Pages
Price
USD 4995
Sample available
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence
Published by
GBI Research
Product code
353594
Published
February 4, 2016
Content info
171 Pages
Price
USD 4995
Sample available
Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents
Published by
GBI Research
Product code
353593
Published
February 1, 2016
Content info
144 Pages
Price
USD 4995
Sample available
Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Product code
351834
Published
January 1, 2016
Content info
166 Pages
Price
USD 4995
Sample available
Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Product code
322141
Published
January 1, 2016
Content info
95 Pages
Price
USD 6995
Sample available